The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance
Abstract
The insulin resistance syndrome (IRS) is associated with dyslipidemia and increased cardiovascular disease risk. A novel method for detailed analyses of lipoprotein subclass sizes and particle concentrations that uses nuclear magnetic resonance (NMR) of whole sera has become available. To define the effects of insulin resistance, we measured dyslipidemia using both NMR lipoprotein subclass analysis and conventional lipid panel, and insulin sensitivity as the maximal glucose disposal rate (GDR) during hyperinsulinemic clamps in 56 insulin sensitive (IS; mean ± SD: GDR 15.8 ± 2.0 mg · kg−1 · min−1, fasting blood glucose [FBG] 4.7 ± 0.3 mmol/l, BMI 26 ± 5), 46 insulin resistant (IR; GDR 10.2 ± 1.9, FBG 4.9 ± 0.5, BMI 29 ± 5), and 46 untreated subjects with type 2 diabetes (GDR 7.4 ± 2.8, FBG 10.8 ± 3.7, BMI 30 ± 5). In the group as a whole, regression analyses with GDR showed that progressive insulin resistance was associated with an increase in VLDL size (r = −0.40) and an increase in large VLDL particle concentrations (r = −0.42), a decrease in LDL size (r = 0.42) as a result of a marked increase in small LDL particles (r = −0.34) and reduced large LDL (r = 0.34), an overall increase in the number of LDL particles (r = −0.44), and a decrease in HDL size (r = 0.41) as a result of depletion of large HDL particles (r = 0.38) and a modest increase in small HDL (r = −0.21; all P < 0.01). These correlations were also evident when only normoglycemic individuals were included in the analyses (i.e., IS + IR but no diabetes), and persisted in multiple regression analyses adjusting for age, BMI, sex, and race. Discontinuous analyses were also performed. When compared with IS, the IR and diabetes subgroups exhibited a two- to threefold increase in large VLDL particle concentrations (no change in medium or small VLDL), which produced an increase in serum triglycerides; a decrease in LDL size as a result of an increase in small and a reduction in large LDL subclasses, plus an increase in overall LDL particle concentration, which together led to no difference (IS versus IR) or a minimal difference (IS versus diabetes) in LDL cholesterol; and a decrease in large cardioprotective HDL combined with an increase in the small HDL subclass such that there was no net significant difference in HDL cholesterol. We conclude that 1) insulin resistance had profound effects on lipoprotein size and subclass particle concentrations for VLDL, LDL, and HDL when measured by NMR; 2) in type 2 diabetes, the lipoprotein subclass alterations are moderately exacerbated but can be attributed primarily to the underlying insulin resistance; and 3) these insulin resistance-induced changes in the NMR lipoprotein subclass profile predictably increase risk of cardiovascular disease but were not fully apparent in the conventional lipid panel. It will be important to study whether NMR lipoprotein subclass parameters can be used to manage risk more effectively and prevent cardiovascular disease in patients with the IRS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
Ferrannini, E., Haffner, S. M., Mitchell, B. D., & Stern, M. P. (1991) · Diabetologia · doi:10.1007/bf00403180 · Cited by 898
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843
Reaven, G. M., Chen, Y. D., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 690
Kennedy, A. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.4.1293 · Cited by 505
The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488
Self-citationOtvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1632 · Cited by 420
Blake, G. J., Otvos, J. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000033222.75187.b9 · Cited by 409
Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.
Otvos, J. D. (2002) · PubMed · Cited by 356
Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M.-R. (1997) · Diabetologia · doi:10.1007/s001250050700 · Cited by 319
Kuller, L., Arnold, A., Tracy, R., Otvos, J., Burke, G., Psaty, B., Siscovick, D., Freedman, D. S., & Kronmal, R. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000022015.97341.3a · Cited by 310
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
Feingold, K. R., Grunfeld, C., Pang, M., Doerrler, W., & Krauss, R. M. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.12.1496 · Cited by 303
Haffner, S. M., D'Agostino, R., Mykkänen, L., Tracy, R., Howard, B., Rewers, M., Selby, J., Savage, P. J., & Saad, M. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.562 · Cited by 297
Rosenson, R. S., Otvos, J. D., & Freedman, D. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02427-x · Cited by 293
Eisenberg, S., Gavish, D., Oschry, Y., Fainaru, M., & Deckelbaum, R. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111444 · Cited by 284
Change in LDL particle size is associated with change in plasma triglyceride concentration.
McNamara, J. R., Jenner, J. L., Li, Z., Wilson, P. W., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1284 · Cited by 275
LDL subclass phenotypes and the insulin resistance syndrome in women.
Selby, J. V., Austin, M. A., Newman, B., Zhang, D., Quesenberry, C. P., Mayer, E. J., & Krauss, R. M. (1993) · Circulation · doi:10.1161/01.cir.88.2.381 · Cited by 237
TERRY, R. B., WOOD, P. D., HASKELL, W. L., STEFANICK, M. L., & KRAUSS, R. M. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-191 · Cited by 179
Barakat, H. A., Carpenter, J. W., McLendon, V. D., Khazanie, P., Leggett, N., Heath, J., & Marks, R. (1990) · Diabetes · doi:10.2337/diab.39.12.1527 · Cited by 173
Physiological role and clinical relevance of high-density lipoprotein subclasses
von Eckardstein, A., Huang, Y., & Assmann, G. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199412000-00003 · Cited by 152
Insulin resistance and coronary heart disease
Laakso, M. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199608000-00008 · Cited by 152
McNamara, J. R., Small, D. M., Li, Z., & Schaefer, E. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37557-x · Cited by 147
Grundy, S. M., & Vega, G. L. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.1.28 · Cited by 145
Rumsey, S. C., Galeano, N. F., Arad, Y., & Deckelbaum, R. J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41409-9 · Cited by 136
Insulin resistance and lipoprotein metabolism
Taskinen, M. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199506000-00007 · Cited by 131
Baron, A., Laakso, M., Brechtel, G., & Edelman, S. V. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115117 · Cited by 127
Taskinen, M. (1990) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80078-3 · Cited by 116
Lahdenper, S., Syv�nne, M., Kahri, J., & Taskinen, M. (1996) · Diabetologia · doi:10.1007/bf00400677 · Cited by 110
Swinkels, D. W., Demacker, P. N. M., Hendriks, J. C. M., & Laar, A. V. '. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.604 · Cited by 105
Haffner, S. M., Agostino, R. B. D., Goff, D. C., Howard, B. V., Festa, A., Saad, M. F., & Mykkänen, L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.9.2234 · Cited by 99
Stewart, M. W., Laker, M. F., Dyer, R. G., Game, F. L., Mitcheson, J., Winocour, P. H., & Alberti, K. G. M. M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.7.1046 · Cited by 89
Changes of lipolytic enzymes cluster with insulin resistance syndrome
Knudsen, P., Eriksson, J., Lahdenper, S., Kahri, J., Groop, L., Taskinen, M., & The Botnia Study Group (1995) · Diabetologia · doi:10.1007/bf00400640 · Cited by 87
Haffner, S. M., Mykk�nen, L., Robbins, D. C., Valdez, R., Miettinen, H., Howard, B. V., Stern, M. P., & Bowsher, R. R. (1995) · Diabetologia · doi:10.1007/bf00401766 · Cited by 85
Low density lipoprotein particle size and risk factors of insulin resistance syndrome
Friedlander, Y., Kidron, M., CASLAKE, M. J., Lamb, T. J., McConnell, M., & Bar-On, H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00215-4 · Cited by 60
Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL.
Lagrost, L., Gambert, P., & Lallemant, C. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.8.1327 · Cited by 59
Festa, A., D'Agostino, R., Mykkänen, L. M., Tracy, R. P., Hales, C. N., Howard, B. V., & Haffner, S. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.10.1688 · Cited by 58
van Tol, A. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510151067866 · Cited by 28
Tilly-Kiesi, M., Knudsen, P., Groop, L., & Taskinen, M. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39139-2 · Cited by 28
MacLean, P. S., Vadlamudi, S., MacDonald, K. G., Pories, W. J., Houmard, J. A., & Barakat, H. A. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80002-5 · Cited by 27
Insulin and lipoprotein metabolism with special reference to the diabetic state
TOMKIN, G. H., & Owens, D. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100303 · Cited by 22
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Self-citationDefinition and diagnostic criteria of clinical obesity
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811
Self-citationJellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Goldberg, R. B., Kendall, D. M., Deeg, M. A., Buse, J. B., Zagar, A. J., Pinaire, J. A., Tan, M. H., Khan, M. A., Perez, A. T., Jacober, S. J., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1547 · Cited by 795
Lipids and Lipoproteins in Patients With Type 2 Diabetes
Krauss, R. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1496 · Cited by 756
Metadata
- Authors
- Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A., Pugh, K., Jenkins, A. J., Klein, R. L., & Liao, Y.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-02-01
- Volume
- 52
- Issue
- 2
- Pages
- 453-462
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2127307547
- Cited by
- 607
- References
- 47
- FWCI
- 15.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.